Physician profile
Marc Robinson
NPI 1619324308
$2,809.62
in general payments reported to CMS, 2019-2025
15 companies · $549 in 2025
The $549 reported for 2025 was more than what 79% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $825 · 2020: $10.51 · 2021: $373 · 2022: $388 · 2023: $275 · 2024: $389 · 2025: $549.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,115 · Entertainment: $97.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.09 |
| Entertainment | $97.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $543.77 | 2019-2021 | |
| Coopervision INC. | $458.06 | 2021-2025 | Misight Contact Lens, Myday Contact Lens, Clariti Contact Lens |
| Alcon Vision LLC | $357.32 | 2019-2025 | Precision7, Clareon, Precision 1 |
| Optos, INC. | $230.84 | 2021-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Johnson & Johnson Vision Care, INC. | $184.51 | 2024-2025 | Acuvue |
| Optovue, INC. | $166.66 | 2019-2021 | |
| Lombart Brothers, INC. | $138.32 | 2024 | Opd-III |
| Novartis Pharmaceuticals Corporation | $124.99 | 2019 | |
| Amgen INC. | $122.35 | 2024 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $118.86 | 2025 | Xdemvy |
| Abb Con-Cise Optical Group LLC | $102.47 | 2019-2020 | |
| Lkc Technologies, INC. | $98.86 | 2025 | |
| Bausch & Lomb Americas INC. | $79.60 | 2022 | |
| Maculogix, INC. | $43.01 | 2019 | |
| Visionix USA, INC | $40.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.